Abstract
Negative reinforcement mechanisms, wherein individuals smoke at regular intervals to ameliorate craving and withdrawal, are integral to persistent smoking. This is consistent with the behavior of dependent smokers butdoes not fully account for the behavior of intermittent smokers, who do not smoke enough to maintain steadynicotine levels. This study examined the independent and combined impacts of nicotine and tobaccoconsumption on cigarette craving, withdrawal, and subsequent smoking behavior in 18 nondependent light andintermittent smokers (LITS) and 23 daily, dependent smokers (DDS). Participants administered conventionalnicotine-containing cigarettes (NC; 18.9 mg nicotine; 1.41 mg deliverable), reduced nicotine content cigarettes(RNC; 0.4 mg nicotine, 0.05 mg deliverable), nicotine inhalers (NI; 10 mg nicotine, 4 mg deliverable), ornicotine-free inhalers (NFI) across 4 sessions following overnight abstinence. Participants rated craving andwithdrawal before and after product administration, then completed a cigarette self-administration task. Forcigarette self-administration, neither smoking status nor product affected latency to initiate smoking; however,LITS were more likely to abstain from smoking and administered fewer puffs than DDS. Across participants,pharmacologically active products (NC, RNC, NI) were associated with fewer cigarette puffs than the NFI.For subjective measures, only cigarettes (NC, RNC) reduced craving in both LITS and DDS. NC, RNC, andNI reduced withdrawal in DDS, while withdrawal remained at floor levels across time points among LITS.While subjective ratings and smoking behavior were largely comparable across LITS and DDS, differingpatterns of withdrawal symptoms suggest that dependent smoking is motivated by negative reinforcementwhile nondependent smoking is not
Original language | English |
---|---|
Pages (from-to) | 605-614 |
Number of pages | 10 |
Journal | Experimental and Clinical Psychopharmacology |
Volume | 29 |
Issue number | 6 |
DOIs | |
Publication status | Published - 2021 |
Bibliographical note
Funding Information:This research was supported by the Natural Sciences and Engineering ResearchCouncil of Canada (NSERC Discovery Grant to Sean P. Barrett) and theDalhousie Psychiatry Research Fund (DPRF to Hera E. Schlagintweit).These funding sources had no other role than financial support. The authorsthank all study participants
Publisher Copyright:
© 2020. American Psychological Association
ASJC Scopus Subject Areas
- Pharmacology
- Psychiatry and Mental health
- Pharmacology (medical)
PubMed: MeSH publication types
- Journal Article